XML 25 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Statement of Cash Flows [Abstract]    
Net loss $ (16,436) $ (109,763)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 31,531 17,727
Non-cash interest expense 509 213
(Gain) loss on disposal of assets (265) 664
Loss on extinguishment of debt 0 1,286
Equity-based compensation 30,995 147,761
Deferred income taxes (3,757) (1,580)
Remeasurement loss on TRAs 1,910 0
Non-cash operating leases 7,299 0
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net (3,771) (182)
Inventories, net (10,301) (2,818)
Prepaid expenses and other current assets (1,283) (2,115)
Other long-term assets 1,161 14
Accounts payable 3,967 5,777
Accrued liabilities 2,208 6,352
Other current liabilities (38) 3,527
Deferred revenue 5,860 5,424
Deferred rent 0 243
Other long-term liabilities (21) (226)
Operating lease liabilities (6,800) 0
Net cash provided by operating activities 42,768 72,304
Cash flows from investing activities:    
Purchases of property and equipment (134,634) (74,121)
Proceeds from disposal of fixed assets 1,274 2,727
Acquisition of shops from franchisees (6,051) (5,387)
Net cash used in investing activities (139,411) (76,781)
Cash flows from financing activities:    
Proceeds from line of credit 122,705 35,000
Payments on line of credit 0 (15,000)
Payments on finance lease obligations (3,144)  
Payments on finance lease obligations   (1,877)
Proceeds from financing lease obligations 0 1,484
Proceeds from long-term debt 1,375 200,000
Payments on long-term debt (1,333) (227,543)
Payments of debt issuance costs (2,749) (2,406)
Proceeds from initial public offering, net of offering costs 0 524,858
Distributions paid to members 0 (213,308)
Payments to repurchase outstanding equity / member units 0 (287,664)
Payments of IPO issuance costs (250) (3,511)
Tax withholding payments upon vesting of equity awards (3,900) (11,333)
Net cash provided by (used in) financing activities 112,704 (1,300)
Net increase (decrease) in cash and cash equivalents 16,061 (5,777)
Cash and cash equivalents, beginning of period 18,506 31,640
Cash and cash equivalents, end of period 34,567 25,863
Supplemental disclosure of cash flow information    
Cash paid for interest 10,134 5,567
Income taxes paid 1,138 676
Supplemental disclosure of noncash investing and financing activities    
Additions of property with capital leases 0 25,317
Additions of property and equipment accrued as of end of period 8,864 2,194
Deferred offering costs accrued 0 543
Transfer between line of credit and term loan facility $ 100,000 $ 0